Kelly Cozens

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 155 citations · Full text

Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · Leukemia · 2022 · 146 citations · Full text

Neuro-oncology, Lymphoid Neoplasia, Transplantation +9

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Luca Ceriani, Lisa Milan, Maurizio Martelli et al. · Blood · 2018 · 107 citations · Full text

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

Andrés J.M. Ferreri, Jeanette K. Doorduijn, Alessandro Re et al. · The Lancet Haematology · 2021 · 96 citations · Full text

CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial

Dean A. Fennell, Emma Kirkpatrick, Kelly Cozens et al. · Trials · 2018 · 45 citations · Full text